United Therapeutics Corporation (UTHR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    United Therapeutics Corpo...

    NASDAQ: UTHR · Real-Time Price · USD
    396.27
    -7.53 (-1.86%)
    At close: Sep 10, 2025, 3:59 PM
    396.50
    0.06%
    After-hours: Sep 10, 2025, 04:54 PM EDT

    United Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.7B 1.21B 961.2M 894.8M
    Short-Term Investments
    		 1.57B 1.79B 1.88B 1.04B
    Long-Term Investments
    		 1.48B 1.91B 1.32B 1.65B
    Other Long-Term Assets
    		 222.1M 151.8M 114.3M 108.2M
    Receivables
    		 279.3M 278.9M 220.4M 198.7M
    Inventory
    		 157.9M 111.8M 102M 93.8M
    Other Current Assets
    		 169.7M 166.2M 219.2M 100.4M
    Total Current Assets
    		 3.87B 3.55B 3.38B 2.32B
    Property-Plant & Equipment
    		 1.22B 1.05B 861.5M 780.9M
    Goodwill & Intangibles
    		 111.9M 114.2M 44.5M 44.6M
    Total Long-Term Assets
    		 3.49B 3.62B 2.66B 2.85B
    Total Assets
    		 7.36B 7.17B 6.04B 5.17B
    Account Payables
    		 6M 5.6M 4.1M 3.8M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 300M 400M n/a n/a
    Other Current Liabilities
    		 432.1M 40.5M 13M 248M
    Total Current Liabilities
    		 738.1M 804.4M 343.2M 305.4M
    Long-Term Debt
    		 n/a 300M 800M 800M
    Other Long-Term Liabilities
    		 181.9M 77.8M 104.6M 104.8M
    Total Long-Term Liabilities
    		 181.9M 377.8M 904.6M 904.8M
    Total Liabilities
    		 920M 1.18B 1.25B 1.21B
    Total Debt
    		 300M 700M 800M 800M
    Common Stock
    		 800K 700K 700K 700K
    Retained Earnings
    		 7.22B 6.03B 5.04B 4.32B
    Comprehensive Income
    		 -3.4M -12.8M -55.5M -23M
    Shareholders Equity
    		 6.44B 5.98B 4.8B 3.96B
    Total Investments
    		 3.05B 3.7B 3.19B 2.69B

    Add to Watchlist